Biotech Values

[iwfal]

however, AMPE’s claim to have an algorithm for dosing a locally administered back-of-the-eye drug according to a patient’s BMI is so far-fetched it really does strike me as funny.

I had missed the local dosing aspect - and would agree that that aspect makes the proposed BMI connection so absurd as to be funny. FWIW.